Healthcare company specializing in diagnostics
2 AI-extracted insights from 2 sources — podcasts, YouTube channels, and X/Twitter accounts.
Not enough scored insights about Guardant Health in the last 30 days yet.
The 2 sources with the most insights about Guardant Health on Kazuha.
AI-generated insights from podcasts, YouTube videos, and X posts — ordered by most recent.
Innovating with blood-based 'liquid biopsies' for colorectal cancer, offering higher patient compliance and leveraging AI for multi-cancer early detection.
A moderately bearish signal, as an insider made a large $17 million sale, his first in a very long time, after the stock ran up 100%. The signal is tempered by his mixed (50%) historical track record.
Innovating with blood-based 'liquid biopsies' for colorectal cancer, offering higher patient compliance and leveraging AI for multi-cancer early detection.
A moderately bearish signal, as an insider made a large $17 million sale, his first in a very long time, after the stock ran up 100%. The signal is tempered by his mixed (50%) historical track record.
Other assets that creators frequently mention in the same content as Guardant Health.
The most active sources covering Guardant Health (GH) on Kazuha are @ceowatcher, Colossus | Investing & Business Podcasts. Kazuha aggregates AI-extracted insights from podcasts, YouTube channels, and X/Twitter accounts.
Kazuha has indexed 2 AI-extracted insights about Guardant Health (GH) from 2 different sources. New insights are added whenever a covered creator publishes a new podcast episode, video, or post.
Creators covering Guardant Health (GH) most frequently also discuss IBKR, AVGO, CVNA, SMMT, ICHR. See the "Discussed alongside" section above for full asset pages.